US64125C1099
US64125C1099
Neurocrine Biosciences, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.860.500.000 | 2.355.300.000 | 21.4% |
| Cost of Revenue | 52.100.000 | 34.000.000 | 53.2% |
| Gross Profit | 2.808.400.000 | 2.321.300.000 | 21.0% |
| 2.171.900.000 | 1.738.300.000 | 24.9% | |
| Operating Income | 636.500.000 | 583.000.000 | 9.2% |
| Pretax Income | 705.400.000 | 486.000.000 | 45.1% |
| Net Income Common Stockholders | 478.600.000 | 341.300.000 | 40.2% |
| -- | -- | -- | |
| -- | -- | -- |